In conclusion, MBL may contribute to graft inflammation and rejection, serving to prime adaptive immunity during ischemia-reperfusion, recurrent acute lung allograft rejection, and bronchiolitis obliterans. This evidence concerns the gene MBL2 and bronchiolitis obliterans syndrome.